Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study
- DOI
- 10.1182/blood.2024027336
- Published
- 2025-06-12
- Container
- Blood
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/blood.2024027336,
title = {Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study},
author = {David J. Kuter and Waleed Ghanima and Nichola Cooper and Howard A. Liebman and Lei Zhang and Yu Hu and Yoshitaka Miyakawa and Wojciech Homenda and Luisa Elena Morales Galindo and Ana Lisa Basquiera and Chuen Wen Tan and Guray Saydam and Marie Luise Hütter-Krönke and Chatree Chai-Adisaksopha and David Gómez-Almaguer and Huy Tran and Ho-Jin Shin and Ademar Dantas da Cunha Junior and Zsolt Lazar and Cristina Pascual Izquierdo and Ilya Kirgner and Elisa Lucchini and Ganna Kuzmina and Michael Fillitz and Sylvain Audia and Minakshi Taparia and Matias Cordoba and Remco Diab and Mengjie Yao and Imene Gouia and Michelle Lee and Ahmed Daak},
year = {2025},
journal = {Blood},
doi = {10.1182/blood.2024027336},
url = {https://doi.org/10.1182/blood.2024027336}
}RIS
TY - JOUR TI - Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study AU - David J. Kuter AU - Waleed Ghanima AU - Nichola Cooper AU - Howard A. Liebman AU - Lei Zhang AU - Yu Hu AU - Yoshitaka Miyakawa AU - Wojciech Homenda AU - Luisa Elena Morales Galindo AU - Ana Lisa Basquiera AU - Chuen Wen Tan AU - Guray Saydam AU - Marie Luise Hütter-Krönke AU - Chatree Chai-Adisaksopha AU - David Gómez-Almaguer AU - Huy Tran AU - Ho-Jin Shin AU - Ademar Dantas da Cunha Junior AU - Zsolt Lazar AU - Cristina Pascual Izquierdo AU - Ilya Kirgner AU - Elisa Lucchini AU - Ganna Kuzmina AU - Michael Fillitz AU - Sylvain Audia AU - Minakshi Taparia AU - Matias Cordoba AU - Remco Diab AU - Mengjie Yao AU - Imene Gouia AU - Michelle Lee AU - Ahmed Daak PY - 2025 JO - Blood DO - 10.1182/blood.2024027336 UR - https://doi.org/10.1182/blood.2024027336 ER -
APA
Kuter, D. J., Ghanima, W., Cooper, N., Liebman, H. A., Zhang, L., Hu, Y., Miyakawa, Y., Homenda, W., Galindo, L. E. M., Basquiera, A. L., Tan, C. W., Saydam, G., Hütter-Krönke, M. L., Chai-Adisaksopha, C., Gómez-Almaguer, D., Tran, H., Shin, H., Junior, A. D. D. C., Lazar, Z., Izquierdo, C. P., Kirgner, I., Lucchini, E., Kuzmina, G., Fillitz, M., Audia, S., Taparia, M., Cordoba, M., Diab, R., Yao, M., Gouia, I., Lee, M., & Daak, A. (2025). Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study. Blood. https://doi.org/10.1182/blood.2024027336
Source records
- crossref · retrieved 2026-09-26T23:36:34.593Z